Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates.

作者: Michael J. McCluskie , Jennifer Thorn , Paul R. Mehelic , Parag Kolhe , Keshab Bhattacharya

DOI: 10.1016/J.INTIMP.2015.02.030

关键词: NicotinePharmacologyDiphtheria toxinHaptenAntigenConjugateAntibodyChemistryImmunogenicityImmunologyConjugate vaccine

摘要: Abstract Anti-nicotine vaccines aim to prevent nicotine entering the brain, and thus reduce or eliminate reward that drives addiction. Those tested in humans date have failed improve quit rates over placebo, possibly because antibody (Ab) responses were insufficient sequester enough blood majority of subjects. We previously shown mice carrier, hapten linker used conjugate antigen each influence function (nicotine-binding capacity) Ab induced. Herein we evaluated immunogenicity 27 lots NIC7–CRM, a 5-aminoethoxy-nicotine (Hapten 7) mutant nontoxic form diphtheria toxin (CRM197), differed three attributes, namely load (number haptens conjugated molecule CRM197), degree aggregation presence adducts (small molecules attached CRM197 via covalent bond during conjugation process). A range functional (reduced brain immunized animals relative non-immunized controls) obtained with different conjugates, which adjuvanted aluminum hydroxide CpG TLR9 agonist. Trends for better conjugates having 11 18, low level high molecular mass species (HMMS) (i.e., not aggregated) more limited testing cynomolgus monkeys confirmed these results. Thus load, are key attributes can induced by NIC7–CRM.

参考文章(37)
S M Owens, D L Lattin, M Polk, M Gunnell, M Zorbas, Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor. Journal of Pharmacology and Experimental Therapeutics. ,vol. 246, pp. 472- 478 ,(1988)
Barbara Bolgiano, Fatme Mawas, Susan E. Yost, Dennis T. Crane, Xavier Lemercinier, Michael J. Corbel, Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide–CRM197 conjugate vaccines Vaccine. ,vol. 19, pp. 3189- 3200 ,(2001) , 10.1016/S0264-410X(01)00024-X
Ruth D. Ellis, Gregory E.D. Mullen, Mark Pierce, Laura B. Martin, Kazutoyo Miura, Michael P. Fay, Carole A. Long, Donna Shaffer, Allan Saul, Louis H. Miller, Anna P. Durbin, A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals Vaccine. ,vol. 27, pp. 4104- 4109 ,(2009) , 10.1016/J.VACCINE.2009.04.077
Barry J Make, Mitchell Nides, Arden G Christen, Elbert D Glover, Clare B Billing, Victor I Reus, Kathryn E Williams, Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. American Journal of Health Behavior. ,vol. 32, pp. 664- 675 ,(2008) , 10.5555/AJHB.2008.32.6.664
Neal L Benowitz, Peyton Jacob III, Daily intake of nicotine during cigarette smoking Clinical Pharmacology and Therapeutics. ,vol. 35, pp. 499- 504 ,(1984) , 10.1038/CLPT.1984.67
Michael M. Meijler, Masayuki Matsushita, Laurence J. Altobell, Peter Wirsching, Kim D. Janda, A new strategy for improved nicotine vaccines using conformationally constrained haptens. Journal of the American Chemical Society. ,vol. 125, pp. 7164- 7165 ,(2003) , 10.1021/JA034805T
Xinyuan Chen, Marco Pravetoni, Brijesh Bhayana, Paul R. Pentel, Mei X. Wu, High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine. ,vol. 31, pp. 159- 164 ,(2012) , 10.1016/J.VACCINE.2012.10.069
Dianna Rynkiewicz, Melinda Rathkopf, Iain Sim, A. Thomas Waytes, Robert J. Hopkins, Lallan Giri, Deborah DeMuria, Janet Ransom, James Quinn, Gary S. Nabors, Carl J. Nielsen, Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers. Vaccine. ,vol. 29, pp. 6313- 6320 ,(2011) , 10.1016/J.VACCINE.2011.05.047
Claire-Anne Siegrist, Maria Pihlgren, Chantal Tougne, Sue M. Efler, Mary Lou Morris, Mohammed J. AlAdhami, D. William Cameron, Curtis L. Cooper, Jenny Heathcote, Heather L. Davis, Paul-Henri Lambert, Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response Vaccine. ,vol. 23, pp. 615- 622 ,(2004) , 10.1016/J.VACCINE.2004.07.014
F. Ivy Carroll, Bruce E. Blough, Ramakrishna R. Pidaparthi, Philip Abraham, Paul K. Gong, Liu Deng, Xiaodong Huang, Melinda Gunnell, Jackson O. Lay, Eric C. Peterson, S. Michael Owens, Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines. Journal of Medicinal Chemistry. ,vol. 54, pp. 5221- 5228 ,(2011) , 10.1021/JM2004943